Akero Therapeutics, Inc. Net Income
Akero Therapeutics, Inc. reported Net Income of -$81.57 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2025-11-07
- Akero Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$81.57M.
- Akero Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2025-06-30 was -$70.50M.
- Akero Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2025-03-31 was -$70.72M.
- Akero Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2024-12-31 was -$70.02M.
- Akero Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2022 was -$112.03M.
- Akero Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2021 was -$100.78M.
- Akero Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2019 was -$43.76M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$81.57M 10-Q · filed 2025-11-07 | -$152.07M derived: sum of 2 quarters · filed 2025-11-07 | -$222.80M 10-Q · filed 2025-11-07 | -$292.82M derived: sum of 4 quarters · filed 2025-11-07 |
| 2025-06-30 | -$70.50M 10-Q · filed 2025-11-07 | -$141.23M 10-Q · filed 2025-08-08 | -$211.25M derived: sum of 3 quarters · filed 2025-11-07 | -$283.96M derived: sum of 4 quarters · filed 2025-11-07 |
| 2025-03-31 | -$70.72M 10-Q · filed 2025-11-07 | -$140.75M derived: sum of 2 quarters · filed 2025-11-07 | -$213.45M derived: sum of 3 quarters · filed 2025-11-07 | -$269.44M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-12-31 | -$70.02M derived: 10-Q 12 month − 10-Q 9 month · filed 2025-11-07 | -$142.73M derived: sum of 2 quarters · filed 2025-11-07 | -$198.72M derived: sum of 3 quarters · filed 2025-11-07 | -$252.06M 10-Q · filed 2025-11-07 |
| 2024-09-30 | -$72.70M 10-Q · filed 2025-11-07 | -$128.69M derived: sum of 2 quarters · filed 2025-11-07 | -$182.04M 10-Q · filed 2025-11-07 | -$237.22M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$55.99M 10-Q · filed 2025-11-07 | -$109.33M 10-Q · filed 2025-08-08 | -$164.52M derived: sum of 3 quarters · filed 2025-11-07 | -$204.18M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-03-31 | -$53.34M 10-Q · filed 2025-11-07 | -$108.53M derived: sum of 2 quarters · filed 2025-11-07 | -$148.19M derived: sum of 3 quarters · filed 2025-11-07 | -$179.27M derived: sum of 4 quarters · filed 2025-11-07 |
| 2023-12-31 | -$55.19M derived: 10-Q 12 month − 10-Q 9 month · filed 2025-11-07 | -$94.84M derived: sum of 2 quarters · filed 2025-11-07 | -$125.93M derived: sum of 3 quarters · filed 2025-11-07 | -$151.76M 10-Q · filed 2025-11-07 |
| 2023-09-30 | -$39.66M 10-Q · filed 2024-11-08 | -$70.74M derived: sum of 2 quarters · filed 2024-11-08 | -$96.57M 10-Q · filed 2024-11-08 | -$119.63M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$31.08M 10-Q · filed 2024-11-08 | -$56.91M 10-Q · filed 2024-08-09 | -$79.97M derived: sum of 3 quarters · filed 2025-02-28 | -$115.52M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$25.83M 10-Q · filed 2024-11-08 | -$48.89M derived: sum of 2 quarters · filed 2025-02-28 | -$84.43M derived: sum of 3 quarters · filed 2025-02-28 | -$111.83M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$23.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$58.60M derived: sum of 2 quarters · filed 2025-02-28 | -$86.00M derived: sum of 3 quarters · filed 2025-02-28 | -$112.03M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$35.54M 10-Q · filed 2023-11-13 | -$62.95M derived: sum of 2 quarters · filed 2023-11-13 | -$88.97M 10-Q · filed 2023-11-13 | -$121.40M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$27.40M 10-Q · filed 2023-11-13 | -$53.43M 10-Q · filed 2023-08-11 | -$85.86M derived: sum of 3 quarters · filed 2024-02-29 | -$110.19M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$26.03M 10-Q · filed 2023-11-13 | -$58.45M derived: sum of 2 quarters · filed 2024-02-29 | -$82.78M derived: sum of 3 quarters · filed 2024-02-29 | -$111.72M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$32.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$56.75M derived: sum of 2 quarters · filed 2024-02-29 | -$85.69M derived: sum of 3 quarters · filed 2024-02-29 | -$100.78M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$24.33M 10-Q · filed 2022-11-04 | -$53.26M derived: sum of 2 quarters · filed 2022-11-04 | -$68.35M 10-Q · filed 2022-11-04 | -$98.06M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | -$28.93M 10-Q · filed 2022-11-04 | -$44.02M 10-Q · filed 2022-08-05 | -$73.73M derived: sum of 3 quarters · filed 2022-11-04 | -$95.14M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-03-31 | -$15.09M 10-Q · filed 2022-11-04 | -$44.80M derived: sum of 2 quarters · filed 2022-11-04 | -$66.20M derived: sum of 3 quarters · filed 2022-11-04 | -$82.41M derived: sum of 4 quarters · filed 2022-11-04 |
| 2020-12-31 | -$29.71M derived: 10-Q 12 month − 10-Q 9 month · filed 2022-11-04 | -$51.11M derived: sum of 2 quarters · filed 2022-11-04 | -$67.32M derived: sum of 3 quarters · filed 2022-11-04 | -$79.21M 10-Q · filed 2022-11-04 |
| 2020-09-30 | -$21.40M 10-Q · filed 2021-11-12 | -$37.61M derived: sum of 2 quarters · filed 2021-11-12 | -$49.50M 10-Q · filed 2021-11-12 | -$65.11M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | -$16.21M 10-Q · filed 2021-11-12 | -$28.09M 10-Q · filed 2021-08-13 | -$43.70M derived: sum of 3 quarters · filed 2022-02-25 | -$59.26M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | -$11.89M 10-Q · filed 2021-11-12 | -$27.50M derived: sum of 2 quarters · filed 2022-02-25 | -$43.05M derived: sum of 3 quarters · filed 2022-02-25 | -$50.28M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | -$15.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$31.16M derived: sum of 2 quarters · filed 2022-02-25 | -$38.39M derived: sum of 3 quarters · filed 2022-02-25 | -$43.76M 10-K · filed 2022-02-25 |
| 2019-09-30 | -$15.55M 10-Q · filed 2020-11-12 | -$22.78M derived: sum of 2 quarters · filed 2020-11-12 | -$28.14M 10-Q · filed 2020-11-12 | -$89.62M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$7.23M 10-Q · filed 2020-11-12 | -$12.59M 10-Q · filed 2020-08-12 | -$74.06M derived: sum of 3 quarters · filed 2020-11-12 | -$85.21M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-03-31 | -$5.36M 10-Q · filed 2020-11-12 | -$66.83M derived: sum of 2 quarters · filed 2020-11-12 | -$77.98M derived: sum of 3 quarters · filed 2020-11-12 | -$86.66M derived: sum of 4 quarters · filed 2020-11-12 |
| 2018-12-31 | -$61.47M derived: 10-Q 12 month − 10-Q 9 month · filed 2020-11-12 | -$72.62M derived: sum of 2 quarters · filed 2020-11-12 | -$81.29M derived: sum of 3 quarters · filed 2020-11-12 | -$81.71M 10-Q · filed 2020-11-12 |
| 2018-09-30 | -$11.15M 10-Q · filed 2019-11-12 | -$19.82M derived: sum of 2 quarters · filed 2019-11-12 | -$20.24M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$8.67M 10-Q · filed 2019-11-12 | -$9.09M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | -$421.00K 10-Q · filed 2019-11-12 |